Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
Benson Chellakkan Selvanesan(Albert Einstein College of Medicine), Claudia Gravekamp(Albert Einstein College of Medicine)
Cited by 4
Related Papers
Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice
|British Journal of Cancer|2013|142
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
|Journal for ImmunoTherapy of Cancer|2020|28
Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction
|Cancer Letters|2023|4
Immunotherapy for ovarian cancer is improved by tumor-targeted delivery of a neoantigen surrogate
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1